FLT3ITD Allelic Ratio Test sale cost 1520 AED
Mesoridazine Test sale cost 1900 AED Mesoridazine Test Cost 2,110 د.إ Original price was: 2,110 د.إ.1,900 د.إCurrent price is: 1,900 د.إ.
NUDT15 Gene Mutation Analysis Test sale cost 1500 AED NUDT15 Gene Mutation Analysis Test Cost 2,000 د.إ Original price was: 2,000 د.إ.1,500 د.إCurrent price is: 1,500 د.إ.
Sale!

FLT3ITD Allelic Ratio Test Cost

Original price was: 2,000 د.إ.Current price is: 1,520 د.إ.

-24%

The FLT3ITD Allelic Ratio Test is a specialized genetic test designed to identify mutations in the FLT3 gene, specifically the internal tandem duplication (ITD) mutations, which are common in acute myeloid leukemia (AML) patients. This test plays a crucial role in the diagnosis, prognosis, and management of AML by determining the allelic ratio of the FLT3ITD mutation. The allelic ratio, which is the proportion of mutant FLT3 to wild-type FLT3, can influence treatment decisions and predict patient outcomes. A higher allelic ratio is often associated with a worse prognosis.

Conducted by DNA Labs UAE, a reputable laboratory known for its advanced genetic testing services, the FLT3ITD Allelic Ratio Test is priced at 1520 AED. The test is performed using sophisticated molecular techniques to ensure accurate and reliable results, which are essential for guiding the therapeutic approach and monitoring disease progression in AML patients. With its state-of-the-art facilities and expert staff, DNA Labs UAE provides a vital service to patients and healthcare providers, contributing to the personalized treatment of acute myeloid leukemia.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

FLT3ITD Allelic Ratio Test

Test Name: FLT3ITD Allelic Ratio Test

Components: EDTA Vacutainer (2ml)

Price: 1520.0 AED

Sample Condition: Bone marrow / Peripheral blood (Transport immediately)

Report Delivery: 8-10 days

Method: Fragment Analysis

Test type: Genetics

Doctor: Gynecologist

Test Department: Pre Test Information

Pre Test Information: FLT3/ITD Allelic Ratio can be done with a Doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details

The FLT3/ITD allelic ratio is a measurement used to determine the ratio of mutant FLT3 gene copies to normal FLT3 gene copies in a patient’s blood or bone marrow sample. FLT3/ITD refers to an internal tandem duplication mutation in the FLT3 gene, which is commonly found in acute myeloid leukemia (AML) and is associated with a poor prognosis.

The allelic ratio is calculated by dividing the peak height or area of the mutant FLT3 allele by the peak height or area of the normal FLT3 allele. This ratio provides important information about the burden of the FLT3/ITD mutation in the patient’s leukemia cells.

A higher allelic ratio indicates a higher proportion of mutant FLT3 gene copies, which is generally associated with a worse prognosis and a higher risk of relapse in AML patients. Monitoring the FLT3/ITD allelic ratio over time can help assess the response to treatment and detect minimal residual disease in AML patients.

Test Name FLT3ITD Allelic Ratio Test
Components EDTA Vacutainer (2ml)
Price 1520.0 AED
Sample Condition Bone marrow \/ Peripheral blood (Transport immediately)
Report Delivery 8-10 days
Method Fragment Analysis
Test type Genetics
Doctor Gynecologist
Test Department:
Pre Test Information FLT3/ITD Allelic Ratio can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

The FLT3/ITD allelic ratio is a measurement used to determine the ratio of mutant FLT3 gene copies to normal FLT3 gene copies in a patient’s blood or bone marrow sample. FLT3/ITD refers to an internal tandem duplication mutation in the FLT3 gene, which is commonly found in acute myeloid leukemia (AML) and is associated with a poor prognosis.

The allelic ratio is calculated by dividing the peak height or area of the mutant FLT3 allele by the peak height or area of the normal FLT3 allele. This ratio provides important information about the burden of the FLT3/ITD mutation in the patient’s leukemia cells.

A higher allelic ratio indicates a higher proportion of mutant FLT3 gene copies, which is generally associated with a worse prognosis and a higher risk of relapse in AML patients. Monitoring the FLT3/ITD allelic ratio over time can help assess the response to treatment and detect minimal residual disease in AML patients.

SKU: TEST-5143 Category:

Related products